tiprankstipranks
Enorama Pharma AB (SE:ERMA)
:ERMA
Sweden Market
ERMA
Enorama Pharma AB
RESEARCH TOOLSreports

Enorama Pharma AB (ERMA) Financial Statements

Compare
0 Followers

Enorama Pharma AB Financial Overview

Enorama Pharma AB's market cap is currently kr27.52M. The company's EPS TTM is kr-0.276; its P/E ratio is -1.77; Enorama Pharma AB is scheduled to report earnings on February 18, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 2.74Mkr 15.77Mkr 1.36Mkr 6.85Mkr 11.04M
Gross Profitkr -62.12Mkr 3.70Mkr -3.90Mkr -616.00Kkr 2.13M
Operating Incomekr -62.12Mkr -47.52Mkr -41.84Mkr -41.47Mkr -26.94M
EBITDAkr -61.65Mkr -20.41Mkr -43.05Mkr -37.22Mkr -26.28M
Net Incomekr -75.14Mkr -43.81Mkr -44.61Mkr -41.78Mkr -28.54M
Balance Sheet
Cash & Short-Term Investmentskr 3.04Mkr 2.08Mkr 6.15Mkr 4.14Mkr 12.20M
Total Assetskr 8.26Mkr 15.89Mkr 34.38Mkr 48.72Mkr 50.93M
Total Debtkr 0.00kr 0.00kr 436.00Kkr 1.91Mkr 3.79M
Net Debtkr -3.04Mkr -2.08Mkr -5.72Mkr -2.23Mkr -8.41M
Total Liabilitieskr 31.71Mkr 8.09Mkr 14.85Mkr 17.20Mkr 29.58M
Stockholders' Equitykr -23.45Mkr 7.80Mkr 19.54Mkr 31.52Mkr 21.35M
Cash Flow
Free Cash Flowkr 0.00kr -35.70Mkr -41.35Mkr -32.96Mkr -31.99M
Operating Cash Flowkr -59.26Mkr -35.70Mkr -41.35Mkr -32.96Mkr -30.16M
Investing Cash Flowkr 0.00kr 0.00kr 0.00kr 0.00kr -1.82M
Financing Cash Flowkr 50.69Mkr 35.29Mkr 41.86Mkr 25.34Mkr 39.51M
Currency in SEK

Enorama Pharma AB Earnings and Revenue History

Income Statement >

Enorama Pharma AB Debt to Assets

Balance Sheet >

Enorama Pharma AB Cash Flow

Cash Flow >

Enorama Pharma AB Forecast EPS vs Actual EPS

Earnings >